Fur-casting Success: Elanco Animal Health Tails Ahead with Raised Revenue Outlook, Stock Soars
Portfolio Pulse from Vandana Singh
Elanco Animal Health Inc (ELAN) reported Q3 FY23 revenue of $1.068 billion, surpassing the consensus of $1.04 billion. Adjusted EPS was $0.18, up from $0.17 a year ago, beating both management guidance and analysts' expectations. The company raised its FY23 revenue guidance to $4.36 billion-$4.4 billion. ELAN shares are up 13.30% at $10.60.
November 07, 2023 | 6:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Elanco's Q3 FY23 revenue and EPS beat expectations, and the company raised its FY23 revenue guidance. This positive news has led to a 13.30% increase in the company's stock price.
Elanco's better-than-expected Q3 FY23 results and raised FY23 revenue guidance indicate strong performance and positive future outlook, which are likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100